Updated charts for products in the pipeline have been uploaded on the CHS website. The CHS publishes four charts, one each for clotting factor concentrates, inhibitor...
by David Page, CHS National Director of Health Policy March 1, 2022, Montréal – The Canadian Hemophilia Society (CHS) was informed yesterday by Héma-Québec that access...
Please CLICK HERE to read the letter sent to the Russian Ambassador in Canada by the Canadian Hemophilia Society and the World Federation of Hemophilia...
by David Page, CHS National Director of Health Policy Access to a wide range of coagulation products is expanding in the provinces and territories served by...
Dear David, This is your 20th anniversary with the CHS and we would like to take this time to extend our deepest gratitude for all...
Mild hemophilia can be very serious and even life-threatening if injuries or bleeds are not treated promptly and adequately. The past few years, a lot...
by David Page, CHS National Director of Health Policy Given recent advances in therapies for inherited bleeding disorders, especially hemophilia A and B, I have...
Montreal, December 16, 2021 – The rollout of emicizumab (Hemlibra) in the provinces and territories served by Canadian Blood Services (CBS) is well underway. Emicizumab...
CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
November 10, 2021 (Montreal) – The Hemlibra rollout continues in provinces served by Canadian Blood Services (CBS). Since access requests from physicians began to be...
November 3, 2021, Ottawa – Canadian Blood Services (CBS) has announced the results of its Request for Proposals (RFP) to supply recombinant factor VIII and...
October 20, 2021, Montreal – Children 12 years of age and under can now access extended half-life (EHL) factor IX in Quebec for the prophylactic...
October 18, 2021, Ottawa – Canadian Blood Services (CBS) announced in its October 18 Customer Letter that the request form for emicizumab (Hemlibra) is now...
Every two or three years, Canadian Blood Services (CBS) and Héma-Québec put out “Requests for Proposals” (RFP) to companies with recombinant factor VIII and IX...
